An overview of the c-MET signaling pathway - sprookjes - yvandenbroek - TriplyDB

An overview of the c-MET signaling pathway

An overview of the c-MET signaling pathway

http://www.wikidata.org/entity/Q24633986

about

Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer Biomarker development in MET-targeted therapy Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms Progress toward overcoming hypoxia-induced resistance to solid tumor therapy Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract c-MET regulates myoblast motility and myocyte fusion during adult skeletal muscle regeneration IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement.Toward precision medicine of breast cancer Current advances in biomarkers for targeted therapy in triple-negative breast cancer Biology of MET: a double life between normal tissue repair and tumor progression Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells Norstictic Acid Inhibits Breast Cancer Cell Proliferation, Migration, Invasion, and In Vivo Invasive Growth Through Targeting C-Met Signaling of Hepatocyte Growth Factor Receptor Src-dependent tyrosine phosphorylation of non-muscle myosin heavy chain-IIA restricts Listeria monocytogenes cellular infection Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.A novel role for ezrin in breast cancer angio/lymphangiogenesis.Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Systemic therapy for advanced hepatocellular carcinoma: an update.Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.Autologous NeoHep Derived from Chronic Hepatitis B Virus Patients' Blood Monocytes by Upregulation of c-MET Signaling.Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash Co-culture of hepatocellular carcinoma cells and human umbilical endothelial cells damaged by SU11274 RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.Expression of c-MET in Invasive Meningioma c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target Topical Application of Oleuropein Induces Anagen Hair Growth in Telogen Mouse Skin.Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).Expression of HGF and c-Met Proteins in Human Keratoconus Corneas.The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma Hypoxia enhances cholangiocarcinoma invasion through activation of hepatocyte growth factor receptor and the extracellular signal‑regulated kinase signaling pathway.A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.SU11274 suppresses proliferation and motility of pancreatic cancer cells.

P2860

Q21129469-7EE5EFA1-A146-4BB5-9DDF-0281222F8388 Q26749110-2B1CBFA6-FDAD-48BE-BA0C-8AF01309FB21 Q26751332-E29B0FF7-460D-410C-A19D-2EF8A779F486 Q26785930-FB4C8C4E-3363-460A-9F29-384B34A05F30 Q26796405-648B0C35-A753-421D-B550-9D0379EF7D3C Q27011423-9B6073E5-1415-4C5B-AA0A-17E716AF454E Q27013620-EA8DFB59-E78D-4CA4-B1FD-332CE4B933EA Q27300880-458CEA1D-6A61-4D2B-A8DC-BCF605145C05 Q27308754-3212893D-6585-4138-977C-E239C3266664 Q27311389-3B65094C-CF07-4939-9ABA-CAB2937811D8 Q28073967-5E968413-F8BB-4C7A-877C-7A803F9A42AE Q28074202-6C7A0C6E-CE89-403B-A04F-804B583333AF Q28085247-BAFAC9E4-64B9-4864-A894-C6CE74C9BE6C Q28509351-492072EB-1F5C-4605-A75A-5BA2800BFC40 Q28547357-504B058D-CD5C-4ACA-BA7B-5004AFB552CD Q28552623-D0BC7AE1-1E51-478A-9865-2A0896C128C3 Q28553147-B7AA85F5-604F-477B-8733-DF329425A9AC Q28828215-8CD20134-8348-4C7F-AEED-8FE7F32E785D Q30230826-38E11452-6AFF-4E64-9008-673FCAE8FE90 Q30360087-38EE982C-EE38-4348-AAAC-5BB650C32281 Q30456266-AEEBC99F-3C9E-443A-A711-7B6374163B0F Q30617722-682DBA88-BA95-426D-BC26-67214A9A65E0 Q31121236-B5D6AEB2-938C-449D-A3E9-64E7527130E0 Q33276007-657C7ACF-E027-4724-8113-20C82EA6AAAC Q33593213-F44AE966-B22A-4C95-BBBE-4BA11D38AD37 Q33649756-96394B0F-25DE-4BFE-885F-F00D8EBAE81B Q33722235-98B665AD-75B8-4AF6-B603-20E1AEEFF6E2 Q33798783-F2175F25-7552-4EC6-9ED2-50BA6EF56286 Q34265415-7205C490-A514-4519-A576-499011B4D89F Q34439333-94F7A8BD-806A-4D7A-A591-D84E559D859F Q34624634-140AE8DD-756E-4550-807E-6C3E7D1E4FB0 Q35170717-1F6E260F-AEAF-4ACA-A4F9-9F299A65E9DB Q35650167-9D8368D0-F350-4CE3-B976-AAADCF6971F6 Q35659349-FD2825B3-13FD-4A3D-BC40-322877279EB7 Q35860664-EF9EAD91-2ADF-40D9-9BB4-EEE1275456C4 Q35876341-17238AFF-38BA-4573-847F-F129E1A3F935 Q35904618-1771BFEF-565F-4ED4-BF2C-7A6C7F0713D5 Q35919809-F5099DE3-3737-42E5-92D1-0719092D5FF0 Q35929320-12491768-3F6D-4C89-B999-3C8B5D19AB66 Q35944581-B520F0BE-A8E3-4A03-81C3-4D5ADE9FE9C3

P2860

An overview of the c-MET signaling pathway

http://www.wikidata.org/entity/Q24633986

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

An overview of the c-MET signaling pathway

@ast

An overview of the c-MET signaling pathway

@en

An overview of the c-MET signaling pathway

@nl

type

label

An overview of the c-MET signaling pathway

@ast

An overview of the c-MET signaling pathway

@en

An overview of the c-MET signaling pathway

@nl

prefLabel

An overview of the c-MET signaling pathway

@ast

An overview of the c-MET signaling pathway

@en

An overview of the c-MET signaling pathway

@nl

P1433

Q24633986-916D9165-CB0E-4646-A7E8-F6755E2C8150

P1476

Q24633986-07020A6C-2353-4CA1-BE9A-A33EAA29889E

P2093

Q24633986-C0DB54BA-6EBA-4B6D-B095-40D443398A06

P2860

Q24633986-00A33F55-1DF9-4BA1-9966-72B79C434D08

Q24633986-01F10E3C-79DC-465C-92DA-B40A03010270

Q24633986-024A23DF-FB03-4D81-B767-E2B580B391E6

Q24633986-03105A40-3914-4016-84AC-318D780A5CD3

Q24633986-0403E983-4593-41EC-8110-6F55A3AF487B

Q24633986-04D50006-868C-430D-BB3C-C31E7CC4AC19

Q24633986-0738224A-A351-43C8-B01D-13D897C3D9B5

Q24633986-08E5E0BB-9E23-4C3A-8DDA-E8A3DA48DEAE

Q24633986-0976DBF9-E58F-4DE9-B780-1C82D23BAE68

Q24633986-09956A1D-2F97-4E5E-8A7F-4382ABAF5F9F

P304

Q24633986-C9C771EA-1DF6-4C97-8C00-4EAC5BE6AD6E

P31

Q24633986-26AC5CF3-763A-4F06-82C8-6DDC720BA9FB

P3181

Q24633986-0A7CDC00-D39B-4E54-A3AD-BEFE0F897114

P356

Q24633986-4C44C37E-4DDF-4891-955D-EB7C213B8001

P407

Q24633986-5FDE5FC2-22E7-4BE8-972F-92991AE191D3

P433

Q24633986-F9CECFEA-B08E-4168-B48B-C3B1F5C5A6F6

P478

Q24633986-E56ECB5A-B485-4049-BDFC-385B9D206052

P50

Q24633986-09B03251-2975-437B-8BFB-85C92DCCF1FC

P577

Q24633986-3876CDA6-1148-4C62-9E9C-DBD0728D63BF

P5875

Q24633986-1CC31673-99B9-44A6-AAB0-64C1D703E08F

P698

Q24633986-AAFC8A0A-3DD3-4254-AE63-8D6AC4BA9FC4

P932

Q24633986-D251F0F9-C6D4-4E8D-9EE2-4B95A2DD5844

P3181

P356

1758834011422556

P1433

Therapeutic advances in medical oncology

P1476

An overview of the c-MET signaling pathway

@en

P2093

Shawna Leslie Organ

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-talk between the proto-oncogenes Met and Ron

Interplay between scatter factor receptors and B plexins controls invasive growth

Molecular cloning and expression of human hepatocyte growth factor

Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase

Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

The Catalogue of Somatic Mutations in Cancer (COSMIC)

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein

P304

S7-S19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2150234

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/1758834011422556

http://www.w3.org/2001/XMLSchema#string

P407

P433

1 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Ming-Sound Tsao

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51841023

http://www.w3.org/2001/XMLSchema#string

P698

22128289

http://www.w3.org/2001/XMLSchema#string

P932

3225017

http://www.w3.org/2001/XMLSchema#string